OSMOTICA PHARMACEUTICALS PLC (OSMT) Forecast, Price Target & Analyst Ratings

NASDAQ:OSMT

Current stock price

1.11
-0.02 (-1.77%)
At close:
1.08
-0.03 (-2.7%)
After Hours:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for OSMOTICA PHARMACEUTICALS PLC (OSMT).

Forecast Snapshot

Consensus Price Target

Price Target
$5.87
+ 428.38% Upside

Next Earnings Forecast

Earnings Estimate
Release Date
N/A
Period
Q4 / 2021
EPS Estimate
-$0.30
Revenue Estimate
3.847M

ChartMill Buy Consensus

Rating
84.00%
Weighted Analyst Rating Score

Price Target Details & History

Consensus Price Target and Range

Mean target
$5.87
Upside
+ 428.38%
From current price of $1.11 to mean target of $5.87, Based on 10 analyst forecasts
Low
$5.05
Median
$5.61
High
$7.35

Price Target Revisions

1 Month
N/A
3 Months
N/A

Price Target Summary

10 Wall Street analysts provided a forecast for the next 12 months for OSMT. The average price target is 5.87 null. This implies a price increase of 428.38% is expected in the next year compared to the current price of 1.11.

Analyst Ratings & History

Current Analyst Ratings

OSMT Current Analyst RatingOSMT Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 1 2 3 4 5

Analyst Ratings History

OSMT Historical Analyst RatingsOSMT Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6 8 10

Analyst Ratings Consensus

ChartMill Buy Consensus
84.00%
OSMT was analyzed by 10 analysts. The buy percentage consensus is at 84. So analysts seem to be very confident about OSMT.
In the previous month the buy percentage consensus was at a similar level.
OSMT was analyzed by 10 analysts. More opinions would make the average more meaningful.

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2021-12-23HC Wainwright & Co.Initiate Buy
2021-09-24Cantor FitzgeraldInitiate Overweight
2021-03-17RBC CapitalMaintains Outperform

Next Earnings Forecast Details

Next Earnings Details

Release Date
N/A
Period
Q4 / 2021
EPS Estimate
-$0.30
Revenue Estimate
3.847M
Revenue Q2Q
-88.86%
EPS Q2Q
65.81%
Number of Analysts
5

Next Earnings Revisions

Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
N/A
EPS (3 Months)
N/A

Next Earnings Summary

Full Analyst Estimates 2021 - 2025

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2018 2019 2020 2021 2022 2023 2024 2025
Revenue
YoY % growth
OSMT revenue by date.OSMT revenue by date.
263.7M
7.33%
240M
-8.99%
177.9M
-25.87%
18.983M
-89.33%
56.684M
198.61%
132.89M
134.44%
325.712M
145.10%
814.28M
150.00%
EBITDA
YoY % growth
OSMT ebitda by date.OSMT ebitda by date.
87.27M
29.38%
60.02M
-31.22%
22.83M
-61.96%
N/AN/AN/AN/AN/A
EBIT
YoY % growth
OSMT ebit by date.OSMT ebit by date.
5.7M
-72.86%
3M
-47.37%
1.8M
-40.00%
N/AN/AN/AN/AN/A
Operating Margin
OSMT operating margin by date.OSMT operating margin by date.
2.16%1.25%1.01%N/AN/AN/AN/AN/A
EPS
YoY % growth
OSMT eps by date.OSMT eps by date.
N/A-2.73
-460.52%
-1.29
52.75%
-1.05
18.29%
-0.72
31.94%
-0.23
67.30%
-0.34
-46.68%
-0.51
-49.62%

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q4 / 21 Q4 / 22
EPS
Q2Q % growth
-0.30
65.81%
-0.05
82.48%
Revenue
Q2Q % growth
3.847M
-88.86%
255.319M
6,537.26%
EBITDA
Q2Q % growth
N/AN/A
EBIT
Q2Q % growth
N/AN/A

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

OSMT Yearly Revenue VS EstimatesOSMT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M
OSMT Yearly EPS VS EstimatesOSMT Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 -1 -2 -3

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
22.05%
EPS Next 5 Year
9.87%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
-9.27%
Revenue Next 5 Year
35.55%

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A

OSMOTICA PHARMACEUTICALS PLC / OSMT Forecast FAQ

Can you provide the average price target for OSMOTICA PHARMACEUTICALS PLC stock?

10 analysts have analysed OSMT and the average price target is 5.87 null. This implies a price increase of 428.38% is expected in the next year compared to the current price of 1.11.

What are the consensus estimates for OSMOTICA PHARMACEUTICALS PLC (OSMT) next earnings?

The consensus EPS estimate for the next earnings of OSMOTICA PHARMACEUTICALS PLC (OSMT) is -0.3 null and the consensus revenue estimate is 3.85M null.

What is the consensus rating for OSMOTICA PHARMACEUTICALS PLC (OSMT) stock?

The consensus rating for OSMOTICA PHARMACEUTICALS PLC (OSMT) is 84 / 100 . This indicates that analysts generally have a positive outlook on the stock.